This article has been updated from a version posted Oct. 15 to include additional information from the company.
Xagenic, a Toronto-based company developing a menu of chip-based tests, recently received over C$1 million ($996,000) in financing from Canadian investors.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
